Performance of Lung Nodule Management Algorithms for Lung-RADS Category 4 Lesions

Acad Radiol. 2021 Aug;28(8):1037-1042. doi: 10.1016/j.acra.2020.04.041. Epub 2020 Jun 12.

Abstract

Purpose: To test the performance of the American College of Chest Physicians (ACCP) and British Thoracic Society (BTS) algorithms to stratify high-risk nodules identified at lung cancer screening.

Method and materials: Patients with Lung-RADS category 4 nodules identified on lung cancer screening computed tomography (CT) between March 2014 and August 2018 were identified, and a subset of 150 were randomly selected. Nodule characteristics and, if available, fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET)-CT scan were recorded. Radiologists blinded to final diagnosis and downstream testing performed five-point visual assessment score for probability of nodule malignancy; their accuracies are averaged below. Probabilities of malignancy according to Brock and Herder models were calculated. ACCP and BTS algorithms were applied to the nodules.

Results: Final diagnosis of malignancy was made in 65/150 (43%) of patients. The sensitivity, specificity and accuracy for nodule malignancy were: radiologist visual score (92%, 85%, 88%); BTS (76%, 91%, 85%); ACCP (63%, 89%, 78%); and Brock calculator (77%, 71%, 73%). The sensitivity, specificity, and accuracy for nodule malignancy in patients with FDG PET-CT scan (n = 78) were: FDG uptake (91%, 64%, 83%); Herder probability (91%, 68%, 83%); radiologist visual score (93%, 69%, 86%); BTS (84%, 64%, 78%); Brock probability (82%, 50%, 72%); and ACCP (68%, 59%, 65%).

Conclusion: Thoracic radiologist visual analysis yielded the greatest accuracy for nodule triage in the entire cohort. BTS performed better than ACCP guidelines and both performed better than the Brock model alone.

Keywords: Lung cancer; Lung-RADS; Nodule; Radiology; Screening.

MeSH terms

  • Algorithms
  • Early Detection of Cancer
  • Fluorodeoxyglucose F18
  • Humans
  • Lung
  • Lung Neoplasms* / diagnostic imaging
  • Lung Neoplasms* / therapy
  • Multiple Pulmonary Nodules* / diagnostic imaging
  • Positron Emission Tomography Computed Tomography
  • Solitary Pulmonary Nodule* / diagnostic imaging
  • Tomography, X-Ray Computed

Substances

  • Fluorodeoxyglucose F18